5872 related articles for article (PubMed ID: 23684677)
21. New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction.
Tschöpe C; Van Linthout S
Curr Heart Fail Rep; 2014 Dec; 11(4):436-44. PubMed ID: 25189801
[TBL] [Abstract][Full Text] [Related]
22. Heart failure with preserved ejection fraction: time for a new approach?
Desai AS
J Am Coll Cardiol; 2013 Jul; 62(4):272-4. PubMed ID: 23684678
[No Abstract] [Full Text] [Related]
23. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
[TBL] [Abstract][Full Text] [Related]
24. Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening.
Sorop O; Heinonen I; van Kranenburg M; van de Wouw J; de Beer VJ; Nguyen ITN; Octavia Y; van Duin RWB; Stam K; van Geuns RJ; Wielopolski PA; Krestin GP; van den Meiracker AH; Verjans R; van Bilsen M; Danser AHJ; Paulus WJ; Cheng C; Linke WA; Joles JA; Verhaar MC; van der Velden J; Merkus D; Duncker DJ
Cardiovasc Res; 2018 Jun; 114(7):954-964. PubMed ID: 29432575
[TBL] [Abstract][Full Text] [Related]
25. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
Dryer K; Gajjar M; Narang N; Lee M; Paul J; Shah AP; Nathan S; Butler J; Davidson CJ; Fearon WF; Shah SJ; Blair JEA
Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1033-H1042. PubMed ID: 29424571
[TBL] [Abstract][Full Text] [Related]
26. [Role of ACE2-Ang (1-7)-Mas receptor axis in heart failure with preserved ejection fraction with hypertension].
Yu J; Wu Y; Zhang Y; Zhang L; Ma Q; Luo X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):738-746. PubMed ID: 30124209
[TBL] [Abstract][Full Text] [Related]
27. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
Brouwers FP; de Boer RA; van der Harst P; Voors AA; Gansevoort RT; Bakker SJ; Hillege HL; van Veldhuisen DJ; van Gilst WH
Eur Heart J; 2013 May; 34(19):1424-31. PubMed ID: 23470495
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction.
Tamaki S; Mano T; Sakata Y; Ohtani T; Takeda Y; Kamimura D; Omori Y; Tsukamoto Y; Ikeya Y; Kawai M; Kumanogoh A; Hagihara K; Ishii R; Higashimori M; Kaneko M; Hasuwa H; Miwa T; Yamamoto K; Komuro I
PLoS One; 2013; 8(7):e68893. PubMed ID: 23894370
[TBL] [Abstract][Full Text] [Related]
29. Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.
Quiroz R; Doros G; Shaw P; Liang CS; Gauthier DF; Sam F
Am J Cardiol; 2014 Feb; 113(4):691-6. PubMed ID: 24484862
[TBL] [Abstract][Full Text] [Related]
30. Heart failure: what does ejection fraction have to do with it?
Iwano H; Little WC
J Cardiol; 2013 Jul; 62(1):1-3. PubMed ID: 23672790
[TBL] [Abstract][Full Text] [Related]
31. Heart failure with preserved ejection fraction: Defining the function of ROS and NO.
Zuo L; Chuang CC; Hemmelgarn BT; Best TM
J Appl Physiol (1985); 2015 Oct; 119(8):944-51. PubMed ID: 25977452
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction.
Zile MR; Gottdiener JS; Hetzel SJ; McMurray JJ; Komajda M; McKelvie R; Baicu CF; Massie BM; Carson PE;
Circulation; 2011 Dec; 124(23):2491-501. PubMed ID: 22064591
[TBL] [Abstract][Full Text] [Related]
33. Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction.
Zhang N; Feng B; Ma X; Sun K; Xu G; Zhou Y
Cardiovasc Diabetol; 2019 Aug; 18(1):107. PubMed ID: 31429767
[TBL] [Abstract][Full Text] [Related]
34. Association between low-grade chronic inflammation and depressed left atrial compliance in heart failure with preserved ejection fraction: A retrospective analysis.
Sani CM; Pogue EPL; Hrabia JB; Zayachkowski AG; Zawadka MM; Poniatowski AG; Długosz D; Leśniak W; Kruszelnicka O; Chyrchel B; Surdacki A
Folia Med Cracov; 2018; 58(2):45-55. PubMed ID: 30467433
[TBL] [Abstract][Full Text] [Related]
35. Competing risks of heart failure with preserved ejection fraction in diabetic patients.
Takeda Y; Sakata Y; Mano T; Ohtani T; Kamimura D; Tamaki S; Omori Y; Tsukamoto Y; Aizawa Y; Komuro I; Yamamoto K
Eur J Heart Fail; 2011 Jun; 13(6):664-9. PubMed ID: 21415098
[TBL] [Abstract][Full Text] [Related]
36. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.
Hamdani N; Paulus WJ; van Heerebeek L; Borbély A; Boontje NM; Zuidwijk MJ; Bronzwaer JG; Simonides WS; Niessen HW; Stienen GJ; van der Velden J
Eur Heart J; 2009 Aug; 30(15):1863-72. PubMed ID: 19487234
[TBL] [Abstract][Full Text] [Related]
37. Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis.
Penicka M; Bartunek J; Trakalova H; Hrabakova H; Maruskova M; Karasek J; Kocka V
J Am Coll Cardiol; 2010 Apr; 55(16):1701-10. PubMed ID: 20394874
[TBL] [Abstract][Full Text] [Related]
38. B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction - Relevance to Age-Related Left Ventricular Modeling in Japanese.
Harada E; Mizuno Y; Kugimiya F; Shono M; Maeda H; Yano N; Kuwahara K; Yasue H
Circ J; 2017 Jun; 81(7):1006-1013. PubMed ID: 28381705
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
[TBL] [Abstract][Full Text] [Related]
40. Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial.
Shah AM; Shah SJ; Anand IS; Sweitzer NK; O'Meara E; Heitner JF; Sopko G; Li G; Assmann SF; McKinlay SM; Pitt B; Pfeffer MA; Solomon SD;
Circ Heart Fail; 2014 Jan; 7(1):104-15. PubMed ID: 24249049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
